Lihong Li
NMPA Key Laboratory For Research And Evaluation Of Drug Metabolism & Guangdong Provincial Key Laboratory Of New Drug Screening & Guangdong Hong Kong Macao Joint Laboratory For New Drug Screening
Guangzhou, 510515, China
Guangzhou, 510515, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Hexahydrocurcumin inhibits osteoclastogenesis and bone destruction in osteoporosis by targeting c-Src.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 01, 2025
Corrigendum to "Erianin serves as an NFATc1 inhibitor to prevent breast cancer-induced osteoclastogenesis and bone destruction" Adv. Res. 69 (2025) 399-411].
Journal: Journal of advanced research
Published: October 09, 2025
Inhibition of ROCK2 impedes osteoclastogenesis through Src-Ca2+-NFATc1 signaling pathway and alleviates ovariectomy-induced bone loss.
Journal: International immunopharmacology
Published: June 25, 2025
Osteoclast precursor cell-derived Flot2 is a novel therapeutic target for bone loss diseases.
Journal: Pharmacological research
Published: January 23, 2025
Erianin serves as an NFATc1 inhibitor to prevent breast cancer-induced osteoclastogenesis and bone destruction.
Journal: Journal of advanced research
Published: January 13, 2024
Flot2 deficiency facilitates B cell-mediated inflammatory responses and endotoxic shock.
Journal: Immunology
Published: March 21, 2023
Polyphyllin VII protects from breast cancer-induced osteolysis by suppressing osteoclastogenesis via c-Fos/NFATc1 signaling.
Journal: International immunopharmacology
Published: February 22, 2023
Dietary inflammatory potential and biological aging among US adults: a population-based study.
Journal: Aging clinical and experimental research
Published: January 27, 2023
Psoralen-loaded polymeric lipid nanoparticles combined with paclitaxel for the treatment of triple-negative breast cancer.
Journal: Nanomedicine (London, England)
Published: November 09, 2021
Key Factor Regulating Inflammatory Microenvironment, Metastasis, and Resistance in Breast Cancer: Interleukin-1 Signaling.
Journal: Mediators of inflammation
Published: June 23, 2021
Activating caspase-8/Bid/ROS signaling to promote apoptosis of breast cancer cells by folate-modified albumin baicalin-loaded nanoparticles.
Journal: Nanotechnology
Published: May 23, 2021
Polymeric Lipid Hybrid Nanoparticles as a Delivery System Enhance the Antitumor Effect of Emodin in Vitro and in Vivo.
Journal: Journal of pharmaceutical sciences
Published: February 24, 2021
Last Updated: 09/26/2026